Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
26 juil. 2024 21h25 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Provides Update on Previously Announced Private Placement
22 juil. 2024 21h55 HE
|
Rakovina Therapeutics Inc
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a...
Rakovina Therapeutics Announces Second Upsizing of Private Placement
19 juil. 2024 09h47 HE
|
Rakovina Therapeutics Inc
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a...
Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting
20 juin 2024 17h34 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update
30 mai 2024 17h52 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
24 mai 2024 16h30 HE
|
Rakovina Therapeutics Inc
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that...
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
23 mai 2024 07h30 HE
|
Rakovina Therapeutics Inc
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a...
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
08 mai 2024 08h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new...
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
26 avr. 2024 20h38 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
09 avr. 2024 16h05 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina” or the “Company”), a biopharmaceutical company dedicated to improving the lives...